William H. Carson - 13 Jun 2023 Form 4 Insider Report for Decibel Therapeutics, Inc.

Role
Director
Signature
/s/ Jeffrey Schulz, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
13 Jun 2023
Net transactions value
$0
Form type
4
Filing time
14 Jun 2023, 16:42:11 UTC
Previous filing
12 Jun 2023
Next filing
25 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBTX Common Stock Award $0 +5,000 $0.000000 5,000 13 Jun 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBTX Stock Option (right to buy) Award $0 +5,000 $0.000000 5,000 13 Jun 2023 Common Stock 5,000 $4.78 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of the Issuer's common stock issuable under 5,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. The RSUs are scheduled to vest in full on the one year anniversary of the date of grant of the RSUs (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the RSUs), subject to the reporting person's continued service.
F2 Includes 5,000 unvested RSUs. Each unvested RSU represents the right to receive one share of the Issuer's common stock upon vesting.
F3 This option was granted on June 13, 2023 for 5,000 shares. The shares underlying the option are scheduled to vest in full on the one year anniversary of the date of grant of the option (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the option), subject to the reporting person's continued service.

Remarks:

Exhibit Index: 24.1 Power of Attorney